Cargando…
Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment
BACKGROUND: The aim of this study was to report the long-term clinical outcomes of patients who received stereotactic body radiotherapy (SBRT) as a boost treatment for head and neck cancer. MATERIALS AND METHODS: Between March 2004 and July 2007, 26 patients with locally advanced, medically inoperab...
Autores principales: | Lee, Dong Soo, Kim, Yeon Sil, Cheon, Jae Seok, Song, Jin Ho, Son, Seok Hyun, Jang, Ji Sun, Kang, Young Nam, Kang, Jing Hyoung, Jung, So Lyoung, Yoo, Ie Ryung, Jang, Hong Seok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412714/ https://www.ncbi.nlm.nih.gov/pubmed/22691266 http://dx.doi.org/10.1186/1748-717X-7-85 |
Ejemplares similares
-
Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer
por: Anwar, Mekhail, et al.
Publicado: (2016) -
Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastases
por: Kornhuber, Christine, et al.
Publicado: (2023) -
Simultaneous integrated boost with stereotactic radiotherapy for dominant intraprostatic lesion of localized prostate cancer: a dosimetric planning study
por: Kim, Yeon Joo, et al.
Publicado: (2020) -
Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR)
por: Kim, Yeon Joo, et al.
Publicado: (2020) -
Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible
por: Lee, Tae Hoon, et al.
Publicado: (2021)